Treatment Resistant Hypertension

Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Microvascular Therapeutics
1 program
1
Endocalyx ProPhase 21 trial
Active Trials
NCT06940011Recruiting64Est. Jan 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Microvascular TherapeuticsEndocalyx Pro

Clinical Trials (1)

Total enrollment: 64 patients across 1 trials

NCT06940011Microvascular TherapeuticsEndocalyx Pro

Endocalyx in Treatment Resistent Hypertension

Start: Jan 2025Est. completion: Jan 202864 patients
Phase 2Recruiting

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
Yesterday
From $150K/yr

Associate Regulatory Affairs Specialist

Medtronic
Mounds View, Minnesota, United States of America
Yesterday
$60K - $90K/yr

Business Development Manager, Post Transplant, Cardio Thoracic

Thermo Fisher Scientific
Remote
Yesterday

Director, Medical Affairs

Abbott
Germany - Hesse - Eschborn
Yesterday

Therapy Development Manager

Abbott
Australia > Doncaster : 666 Doncaster Road
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 64 patients
1 companies competing in this space

Related Indications

Hypertension(361)Heart Failure(347)Coronary Artery Disease(302)Atrial Fibrillation(290)Pulmonary Arterial Hypertension(106)Acute Coronary Syndrome(67)Pulmonary Hypertension(57)Atherosclerosis(44)Hypertension, Pulmonary(34)Essential Hypertension(32)